Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on December 8th, 2023%
The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration. . . . → Read More: Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track
By Alan, on November 27th, 2023%
A vaccine delivered with a patch device is shown in a clinical trial to generate neutralizing antibodies against measles and rubella similar to conventional injections. . . . → Read More: Vaccine Patch Shown Safe, Produces Measles/Rubella Antibodies
By Alan, on September 13th, 2023%
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment
By Alan, on June 6th, 2023%
Initial results from a clinical trial show a patch device delivering a Covid-19 vaccine is well tolerated by recipients and triggers a measurable immune response. . . . → Read More: Vaccine Patch Shown Safe, Induces Immune Response
By Alan, on June 1st, 2023%
A clinical trial is underway testing an experimental therapy for peanut allergy that its developer says trains the immune system without using peanut proteins. . . . → Read More: Clinical Trial Begins for Peanut Allergy Treatment
By Alan, on March 31st, 2023%
A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians. . . . → Read More: Self-Applied Patch Shown Feasible for Vaccine Delivery
By Alan, on February 13th, 2023%
An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus. . . . → Read More: Nasal Spray Reduces Flu Duration in Challenge Trial
By Alan, on February 10th, 2023%
A clinical trial has begun testing a commercially-available flu vaccine administered with a painless patch device against conventional syringe injection delivery. . . . → Read More: Clinical Trial Underway Testing Influenza Vaccine Patch
By Alan, on November 8th, 2022%
Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia. . . . → Read More: Covid-19 Vaccine Patch Clinical Trial Begins
By Alan, on April 25th, 2022%
First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers. . . . → Read More: Early Trials Show Responses for Some Blood Cancers
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|